The role of p53 in determining sensitivity to radiotherapy
Top Cited Papers
- 1 February 2003
- journal article
- review article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 3 (2) , 117-129
- https://doi.org/10.1038/nrc992
Abstract
Ionizing radiation (IR) has proven to be a powerful medical treatment in the fight against cancer. Rational and effective use of its killing power depends on understanding IR-mediated responses at the molecular, cellular and tissue levels. Tumour cells frequently acquire defects in the molecular regulatory mechanisms of the response to IR, which sensitizes them to radiation therapy. One of the key molecules involved in a cell's response to IR is p53. Understanding these mechanisms indicates new rational approaches to improving cancer treatment by IR.Keywords
This publication has 108 references indexed in Scilit:
- Live or let die: the cell's response to p53Nature Reviews Cancer, 2002
- Checking in on Cds1 (Chk2): A checkpoint kinase and tumor suppressorBioEssays, 2002
- The role of p53 in death of IL-3-dependent cells in response to cytotoxic drugsOncogene, 2000
- Bcl-2 with loss of apoptosis allows accumulation of genetic alterations: A pathway to metastatic progression in human breast cancerInternational Journal of Cancer, 2000
- Epithelial Cells of Different Organs Exhibit Distinct Patterns of p53-Dependent and p53-Independent Apoptosis Following DNA InsultExperimental Cell Research, 1999
- Disruption of p53 in human cancer cells alters the responses to therapeutic agentsJournal of Clinical Investigation, 1999
- Could p53 be a target for therapeutic suppression?Seminars in Cancer Biology, 1998
- Transgenic mice with p53-responsive lacZ: p53activity varies dramatically during normal development and determines radiation and drug sensitivity invivoThe EMBO Journal, 1997
- p53 Status and the Efficacy of Cancer Therapy in VivoScience, 1994
- p53 is required for radiation-induced apoptosis in mouse thymocytesNature, 1993